Bernardo Canedo Bizzo, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Artificial Intelligence | 15 | 2023 | 2214 | 1.780 |
Why?
|
| Radiology | 8 | 2023 | 2100 | 1.020 |
Why?
|
| Kidney Calculi | 2 | 2022 | 465 | 0.590 |
Why?
|
| Decision Support Systems, Clinical | 3 | 2021 | 1164 | 0.540 |
Why?
|
| Pneumothorax | 2 | 2022 | 379 | 0.500 |
Why?
|
| Tracheomalacia | 1 | 2022 | 63 | 0.420 |
Why?
|
| Calcium Oxalate | 1 | 2022 | 74 | 0.420 |
Why?
|
| Cognitive Reserve | 1 | 2020 | 76 | 0.360 |
Why?
|
| Lithotripsy | 1 | 2020 | 143 | 0.350 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2023 | 20129 | 0.350 |
Why?
|
| Radiography, Thoracic | 3 | 2023 | 1265 | 0.350 |
Why?
|
| Pleural Effusion | 1 | 2022 | 338 | 0.340 |
Why?
|
| Emphysema | 1 | 2021 | 247 | 0.330 |
Why?
|
| Pulmonary Emphysema | 1 | 2021 | 672 | 0.270 |
Why?
|
| Rest | 1 | 2020 | 901 | 0.260 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2021 | 740 | 0.260 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2020 | 518 | 0.260 |
Why?
|
| Triage | 1 | 2022 | 976 | 0.250 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2021 | 3327 | 0.240 |
Why?
|
| Algorithms | 8 | 2022 | 13881 | 0.240 |
Why?
|
| Neurology | 1 | 2022 | 763 | 0.240 |
Why?
|
| Lung | 6 | 2023 | 9856 | 0.230 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 1 | 2013 | 33 | 0.220 |
Why?
|
| Cerebral Cortex | 2 | 2020 | 5708 | 0.210 |
Why?
|
| Diagnostic Imaging | 2 | 2023 | 3507 | 0.190 |
Why?
|
| Pneumonia | 1 | 2022 | 2133 | 0.190 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 2569 | 0.180 |
Why?
|
| Memory Disorders | 1 | 2016 | 1184 | 0.170 |
Why?
|
| Pulmonary Embolism | 1 | 2022 | 2376 | 0.170 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 1177 | 0.160 |
Why?
|
| Nerve Net | 1 | 2020 | 2174 | 0.160 |
Why?
|
| Computers | 2 | 2021 | 612 | 0.160 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2021 | 1184 | 0.160 |
Why?
|
| Radiation Protection | 1 | 2021 | 419 | 0.150 |
Why?
|
| Guideline Adherence | 1 | 2017 | 2266 | 0.140 |
Why?
|
| Angiography | 2 | 2022 | 1639 | 0.140 |
Why?
|
| Health Personnel | 1 | 2019 | 3218 | 0.130 |
Why?
|
| Pancreatic Diseases | 1 | 2018 | 350 | 0.130 |
Why?
|
| Humans | 35 | 2023 | 744343 | 0.130 |
Why?
|
| Radiography | 3 | 2023 | 7023 | 0.120 |
Why?
|
| ROC Curve | 2 | 2022 | 3527 | 0.120 |
Why?
|
| Quality Improvement | 1 | 2019 | 3749 | 0.120 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2016 | 2104 | 0.120 |
Why?
|
| Retrospective Studies | 9 | 2023 | 77449 | 0.110 |
Why?
|
| Neurosyphilis | 1 | 2012 | 22 | 0.110 |
Why?
|
| Oxalates | 1 | 2022 | 105 | 0.110 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2012 | 60 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2023 | 35421 | 0.100 |
Why?
|
| Prognosis | 5 | 2022 | 29063 | 0.090 |
Why?
|
| Adult | 11 | 2023 | 214055 | 0.090 |
Why?
|
| Phosphates | 1 | 2022 | 786 | 0.080 |
Why?
|
| Middle Aged | 10 | 2023 | 213383 | 0.080 |
Why?
|
| Male | 14 | 2022 | 350118 | 0.080 |
Why?
|
| Radiation Dosage | 2 | 2021 | 1928 | 0.080 |
Why?
|
| Workflow | 1 | 2023 | 847 | 0.080 |
Why?
|
| Depression | 1 | 2017 | 7766 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 13102 | 0.080 |
Why?
|
| Commerce | 1 | 2023 | 592 | 0.080 |
Why?
|
| Uric Acid | 1 | 2022 | 766 | 0.070 |
Why?
|
| Trachea | 1 | 2022 | 1076 | 0.070 |
Why?
|
| Incidental Findings | 1 | 2021 | 689 | 0.070 |
Why?
|
| Organ Size | 1 | 2021 | 2252 | 0.070 |
Why?
|
| Aged | 6 | 2023 | 163280 | 0.060 |
Why?
|
| Software | 2 | 2021 | 4443 | 0.060 |
Why?
|
| Female | 11 | 2022 | 380194 | 0.060 |
Why?
|
| Abdomen | 1 | 2020 | 1118 | 0.060 |
Why?
|
| Temporal Lobe | 1 | 2012 | 1670 | 0.060 |
Why?
|
| Aorta | 1 | 2022 | 2061 | 0.060 |
Why?
|
| United States Food and Drug Administration | 1 | 2021 | 1584 | 0.060 |
Why?
|
| Stroke | 1 | 2023 | 9981 | 0.050 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2023 | 475 | 0.040 |
Why?
|
| Italy | 1 | 2021 | 832 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15540 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2022 | 40561 | 0.040 |
Why?
|
| Contrast Media | 1 | 2022 | 5300 | 0.040 |
Why?
|
| Iran | 1 | 2021 | 708 | 0.040 |
Why?
|
| Arm | 1 | 2021 | 589 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 14722 | 0.040 |
Why?
|
| Information Storage and Retrieval | 1 | 2013 | 824 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2022 | 4371 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3528 | 0.030 |
Why?
|
| Kidney | 1 | 2020 | 7186 | 0.030 |
Why?
|
| Electronic Health Records | 2 | 2021 | 4468 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 8949 | 0.030 |
Why?
|
| Research Design | 1 | 2019 | 5987 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 7659 | 0.030 |
Why?
|
| Young Adult | 2 | 2021 | 56430 | 0.030 |
Why?
|
| Pandemics | 2 | 2021 | 8388 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5078 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 39050 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2013 | 6150 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 57776 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 25043 | 0.020 |
Why?
|
| United States | 1 | 2021 | 69872 | 0.010 |
Why?
|
| Adolescent | 1 | 2022 | 85781 | 0.010 |
Why?
|
| Brain | 1 | 2020 | 26385 | 0.010 |
Why?
|